Martin Doerfler

NIH to Feinstein: Stick out that chest (bioelectrically)

By GREGORY ZELLER // With new treatments for obesity, heart failure and a host of other conditions in sight, a Feinstein Institute researcher will zero in on specific abdominal targets in a new “precision bioelectronic medicine” study. North Shore University Hospital and Long Island Jewish Medical Center Chief of Gastroenterology Larry Miller, who also directs the Gastroenterology Laboratory at the Feinstein Institute for Medical Research, has received a $1.4 million National Institutes of Health grant…


Nerve-stim startup Sanguistat shuffles its deck

By GREGORY ZELLER // A Connecticut-based biotech spun out of the Feinstein Institute for Medical Research has assembled a powerful collection of advisors and directors, including corporate heavyweights and recognized global leaders in the burgeoning field of biolelectronic medicine. Sanguistat Inc., a 2016 clinical-stage medical-device startup, has named Feinstein Institute President and CEO Kevin Tracey as chairman of its Scientific Advisory Board, a role that will leverage the pioneer’s decades of groundbreaking bioelectronics research. The…


New partnership to bring telehealth home

By GREGORY ZELLER // A large-scale investment by Northwell Ventures will put a futuristic spin on the old-fashioned house call. The Northwell Health system on Wednesday announced a new partnership with Virginia-based telehealth solutions provider Avizia Inc. aimed at “expanding the depth and reach of Northwell’s telehealth services, helping to effectively and efficiently provide patients with the right care at the right time and place,” Northwell said in a statement – and yes, that includes…